Package Leaflet: Information for the User
Aricept 10 mg Film-Coated Tablets
Donepezil Hydrochloride
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet:
Aricept belongs to a group of medications called acetylcholinesterase inhibitors. Donepezil hydrochloride increases the levels in the brain of a substance related to memory (acetylcholine) by reducing the breakdown of this substance.
It is used to treat the symptoms of mild to moderately severe Alzheimer's disease. The symptoms include increased memory loss, confusion, and changes in behavior.
Do not take Aricept:
Warnings and Precautions
Consult your doctor before starting to take Aricept if you have or have had:
You should avoid taking Aricept with other acetylcholinesterase inhibitors and other agonists or antagonists of the cholinergic system.
Other Medications and Aricept
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, especially if you are taking any of the following medications:
In the event of surgical intervention with general anesthesia, you should inform your doctor that you are taking Aricept, as this may affect the amount of anesthetic needed.
Aricept can be used in patients with mild to moderate kidney or liver disease. Inform your doctor before starting treatment if you have kidney or liver problems. Patients with severe liver disease should not take Aricept.
Taking Aricept with Food, Drinks, and Alcohol
This medication should be taken with a little water.
Aricept should not be taken with alcohol, as alcohol may alter the effect of this medication.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
You should not take Aricept if you are breastfeeding your child.
Driving and Using Machines
Your illness may affect your ability to drive or use machinery, and you should not perform these activities unless your doctor tells you it is safe to do so. Aricept may cause fatigue, dizziness, somnolence, and muscle cramps, mainly at the start of treatment or when increasing the dose. If you experience these effects, you should not drive or use machinery.
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.
Aricept is administered orally.
Treatment with Aricept starts with a 5 mg tablet, taken once a day with a little water, at night immediately before bedtime. After a month of treatment, your doctor may recommend increasing the dose to 10 mg, once a day, at night. The maximum recommended dose is 10 mg per day.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend taking Aricept in the morning.
If you have mild to moderate liver or kidney impairment, you can take Aricept. Inform your doctor before starting treatment if you have liver or kidney problems. Patients with severe liver impairment should not take Aricept.
Use in Children
Aricept is not recommended for use in children.
If You Take More Aricept Than You Should
If you have taken more Aricept than you should, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount used.
Symptoms of overdose may include nausea, vomiting, drooling, sweating, decreased heart rate, low blood pressure, breathing problems, loss of consciousness, and seizures.
If You Forget to Take Aricept
Do not take a double dose to make up for forgotten doses.
If You Stop Taking Aricept
Do not stop taking Aricept unless your doctor tells you to. If you stop taking Aricept, the benefits of treatment will gradually disappear.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medications, Aricept can cause side effects, although not everyone will experience them.
The following side effects have been reported by people taking Aricept.
Contact your doctor if you experience any of these side effects during treatment with Aricept.
Serious Side Effects:
You should inform your doctor immediately if you notice any of the following serious side effects, as you may need urgent medical treatment.
The estimated frequency of side effects is as follows:
Very Common: May Affect More Than 1 in 10 Patients
Common: May Affect 1 to 10 in 100 Patients
Uncommon: May Affect 1 to 10 in 1,000 Patients
Rare: May Affect 1 to 10 in 10,000 Patients
Frequency Not Known (Cannot Be Estimated from Available Data)
Reporting Side Effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use, Website: www.notificaRAM.es
Keep this medication out of the sight and reach of children.
Store below 30°C.
Do not use Aricept after the expiration date stated on the carton. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Place the packaging and any unused medication in the SIGRE collection point at the pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Aricept 10 mg Film-Coated Tablets
Appearance of the Product and Package Contents
Aricept 10 mg film-coated tablets are available in a pack size with a unit dose blister formed by PVC with an aluminum foil on the back, containing 28 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
Manufacturer:
Fareva Amboise
Zone Industrielle
29 route des Industries
37530 Pocé-sur-Cisse
France
or
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Eisai Farmacéutica, S.A.
Parque Empresarial Cristalia.
Calle Via de los Poblados 3, Edf. 7/8
4th floor
28033 Madrid
Phone: + (34) 91 455 94 55
Date of the last revision of this package leaflet: December 2022
"Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/"